Data as of Nov 4, 2026.
ARKK vs FMED: Holdings Overlap & Returns
Over the year to Nov 4, 2026, ARKK returned −3.7% to FMED's +27.4%; 7% of their weight is in the same names.
askIQ about this page
askIQ about ARKK and FMEDNet assets: $5.9bn on Nov 2, 2026 for ARK Innovation ETF, and $52m on Sep 30, 2026 for Fidelity Disruptive Medicine ETF.
36% of ARKK's weight is in S&P 500 companies and 64% is outside the index. Holdings as of Nov 2, 2026.
22% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.
Pair scorecard
FMED costs 0.25 points a year less; their one-year returns differ by 31.1 points.
Points (pts) are percentage points.
| Measure | ARKK | FMED |
|---|---|---|
| Return | ||
| Total return, 1 year | −3.7% | +27.4% |
| Drawdown | ||
| Below its all-time high | 48.0%, high on Feb 12, 2021 | |
| Against its benchmark | ||
| What it tracks | Broad innovation and megatrends | Broad innovation and megatrends |
| Against the S&P 500, 1 year | behind by 18.5 pts | |
| Its benchmark, total return, 1 year | +14.8% | |
| Against its benchmark, 1 year | behind by 18.5 pts | |
| Cost and size | ||
| Expense ratio | 0.75% | 0.50% |
| Net assets, ARKK as of Nov 2, 2026 and FMED as of Sep 30, 2026 | $5.9bn | $52m |
| Holdings | ||
| Holdings in common | 7% | |
What they share
By the books each fund has filed, ARKK and FMED hold 7% of their money in the same securities at the same weight. Holdings dated Aug 31, 2026 and Nov 2, 2026.
half
7% in common
Only in one fund ↓
Window by window
| Total return | vs its benchmark | |||
|---|---|---|---|---|
| Window | ARKK | FMED | ARKK | FMED |
| 3 months | +5.5% | +14.9% | +5.6 pts vs VOO | not measured |
| 6 months | +1.0% | +31.2% | −4.0 pts vs VOO | not measured |
| 1 year | −3.7% | +27.4% | −18.5 pts vs VOO | not measured |
| 3 years | +98.7% | +57.8% | +15.4 pts vs VOO | not measured |
| Since launchNot the same days: ARKK Oct 2014 · FMED Jun 2023 | +336.0% | +31.7% | −31.3 pts vs VOO | not measured |
Side by side
As of Nov 4, 2026. Source: ETFIQ.
7% of the two portfolios are the same securities at the same weight.
ARKK
By weight, 36% of ARKK's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 86%. The top ten holdings are 50% of the fund across 46 positions, as published by its issuer for Nov 2, 2026. Over the year to Nov 4, 2026 the fund returned −3.7% with distributions reinvested against +14.8% for its benchmark, the S&P 500 Index, so a holder was behind by 18.5 pts. It sits 48.0% below its all-time high of Feb 12, 2021.
FMED
By weight, 22% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 33% of the fund across 72 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +27.4% with distributions reinvested.
Questions people ask
- Do ARKK and FMED hold the same stocks?
- By their latest filings, 7% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Every number is an ETFIQ calculation with distributions reinvested.
Cite this pageCitation, APA and Markdown
ETFIQ, ARKK against FMED, data as of Nov 4, 2026. https://etfiq.com/compare/themes/arkk-vs-fmed
ETFIQ. (Nov 4, 2026). ARKK against FMED. Retrieved from https://etfiq.com/compare/themes/arkk-vs-fmed
[ARKK against FMED (ETFIQ, Nov 4, 2026)](https://etfiq.com/compare/themes/arkk-vs-fmed)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.